Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00051571 | Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma | completed | Phase 2 | 60 | Seagen Inc.INDUSTRY | 1 | Oct 24, 2011 | clinicaltrials |
| NCT00086333 | FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma | completed | Phase 2 | 30 | Seagen Inc.INDUSTRY | 1 | Oct 24, 2011 | clinicaltrials |
| NCT00191308 |
| Molecular Profiling in Lung Cancer Patients |
| completed |
| Phase 2 |
| 30 |
| Eli Lilly and CompanyINDUSTRY |
| 1 |
| Oct 21, 2011 |
| clinicaltrials |
| NCT00008372 | Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer | completed | Phase 2 | — | City of Hope Medical CenterOTHER | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00046787 | Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer | completed | Phase 2 | 47 | Astellas Pharma IncINDUSTRY | 2 | Oct 20, 2011 | clinicaltrials |
| NCT00072618 | Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients | completed | Phase 1 / Phase 2 | 52 | Astellas Pharma IncINDUSTRY | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00085826 | A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients | completed | Phase 3 | 600 | Astellas Pharma IncINDUSTRY | 1 | Oct 20, 2011 | clinicaltrials |
| NCT01332240 | External ValidatIon Trial of ASTER Trial(EVITA) | unknown | N/A | 255 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Oct 19, 2011 | clinicaltrials |
| NCT00932854 | A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY)(REMEDY) | unknown | N/A | 75 | University College London HospitalsOTHER | 1 | Oct 18, 2011 | clinicaltrials |
| NCT00356122 | Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 53 | SanofiINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT01452971 | A Study of the Interaction Between Tumor Susceptibility Gene Glycine N-methyltransferase (GNMT) and Lung Cancer | unknown | — | 200 | China Medical University HospitalOTHER | 0 | Oct 17, 2011 | clinicaltrials |
| NCT00451880 | Study of XL281 in Adults With Solid Tumors | completed | Phase 1 | 180 | ExelixisINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT01103089 | Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP) | completed | — | 10 | AstraZenecaINDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT01449357 | Zalutumumab in Non-Small Cell Lung Cancer (NSCLC) Patients Refractory to Tyrosine Kinase Inhibitors | withdrawn | Phase 2 | 0 | GenmabINDUSTRY | 0 | Oct 10, 2011 | clinicaltrials |
| NCT00335491 | Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors | completed | N/A | 49 | University of UtahOTHER | 1 | Sep 30, 2011 | clinicaltrials |
| NCT01300702 | Neuropathic in the Acute Post Operative Phase | terminated | — | 0 | Rigshospitalet, DenmarkOTHER | 1 | Sep 29, 2011 | clinicaltrials |
| NCT01442909 | Pemetrexed Followed by Docetaxel or in Reverse Sequence | completed | Phase 4 | 44 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Sep 29, 2011 | clinicaltrials |
| NCT01274858 | Sensory Mapping and Thermal Thresholds After Thoracic Surgery | completed | — | 12 | Rigshospitalet, DenmarkOTHER | 1 | Sep 28, 2011 | clinicaltrials |
| NCT00516022 | Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.(Iscador) | completed | Phase 2 | 79 | Rambam Health Care CampusOTHER | 1 | Sep 27, 2011 | clinicaltrials |
| NCT00749346 | NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 42 | NovoCure Ltd.INDUSTRY | 1 | Sep 27, 2011 | clinicaltrials |
| NCT00380055 | Reducing Cancer Disparities for American Indians in the Rural Intermountain West | completed | N/A | 1,800 | University of UtahOTHER | 1 | Sep 21, 2011 | clinicaltrials |
| NCT01112631 | Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy | completed | — | 293 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Sep 20, 2011 | clinicaltrials |
| NCT00686322 | Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC) | completed | Phase 4 | 6 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Sep 15, 2011 | clinicaltrials |
| NCT00437749 | A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer | terminated | Phase 3 | 214 | CBA ResearchINDUSTRY | 1 | Sep 9, 2011 | clinicaltrials |
| NCT00752115 | Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 120 | Hamamatsu UniversityOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00881296 | Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer(GEEP) | completed | Phase 2 | 60 | Hamamatsu UniversityOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT01429766 | A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients | unknown | Phase 2 | 100 | Tata Memorial HospitalOTHER_GOV | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00213733 | Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer | completed | — | 150 | University Hospital, Strasbourg, FranceOTHER | 1 | Aug 30, 2011 | clinicaltrials |
| NCT00180154 | Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET | completed | — | 50 | Technische Universität DresdenOTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT01417806 | Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer | unknown | Phase 2 | 28 | South Florida Veterans Affairs Foundation for Research and EducationFED | 1 | Aug 16, 2011 | clinicaltrials |
| NCT00520676 | Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 3 | 260 | Eli Lilly and CompanyINDUSTRY | 6 | Aug 10, 2011 | clinicaltrials |
| NCT00519805 | Dalteparin in Preventing Blood Clots in Patients With Lung Cancer | unknown | Phase 3 | 2,200 | Velindre NHS TrustOTHER_GOV | 1 | Aug 8, 2011 | clinicaltrials |
| NCT00862030 | CT-Based Versus Conventional Simulation for Palliative Radiotherapy of Non-Small Cell Lung Cancer | completed | — | 20 | Alberta Health servicesOTHER | 1 | Aug 8, 2011 | clinicaltrials |
| NCT01097317 | First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer | unknown | Phase 2 | 52 | Wales Cancer Trials UnitOTHER | 1 | Aug 8, 2011 | clinicaltrials |
| NCT01185314 | To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)(PIONEER) | completed | N/A | 1,270 | AstraZenecaINDUSTRY | 7 | Aug 8, 2011 | clinicaltrials |
| NCT00115518 | Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 30 | Heidelberg UniversityOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT00005989 | R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer | completed | Phase 2 | — | Mayo ClinicOTHER | 1 | Aug 4, 2011 | clinicaltrials |
| NCT01391260 | Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 30 | ZhuGuangYingINDUSTRY | 1 | Aug 2, 2011 | clinicaltrials |
| NCT00260871 | Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications | unknown | — | 1,500 | National Health Research Institutes, TaiwanOTHER | 1 | Jul 29, 2011 | clinicaltrials |
| NCT00830245 | A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer | terminated | Phase 2 | 20 | Clinical Research Center for Solid Tumor, KoreaOTHER | 1 | Jul 26, 2011 | clinicaltrials |
| NCT00040638 | Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 40 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00047801 | Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 28 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00077883 | TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 50 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT01401192 | Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase Expression | unknown | Phase 2 | 304 | Samsung Medical CenterOTHER | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00708812 | Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 126 | Shandong Simcere-Medgenn Bio-pharmaceutical Co., LtdINDUSTRY | 1 | Jul 21, 2011 | clinicaltrials |
| NCT00522886 | Phase I Cetuximab and Concurrent Radio-chemotherapy | completed | Phase 1 | 24 | Maastricht Radiation OncologyOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT01282450 | Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 60 | Maastricht Radiation OncologyOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00970645 | Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer | terminated | N/A | 2 | Mayo ClinicOTHER | 1 | Jul 18, 2011 | clinicaltrials |
| NCT00530205 | Effects of Radiation Therapy on the Body in Patients With Stage III Non-Small Cell Lung Cancer | withdrawn | — | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 14, 2011 | clinicaltrials |
Data updated 24 days agoSource updated Oct 24, 2011source: clinicaltrials